Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Heron Therapeutics, Inc.”

37 pharma patents match "Heron Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 37
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 37 pharmaceutical patents matching "Heron Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

37 results for “Heron Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 12318376

    Compositions of a polyorthoester and an aprotic solvent

    Heron Therapeutics, Inc. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted

  2. US 12290520

    Methods of use of emulsion formulations of aprepitant

    Heron Therapeutics, Inc. · Granted May 6, 2025 · Expires May 1, 2045

    granted

  3. US 12115254

    Methods of use of emulsion formulations of an NK-1 receptor antagonist

    Heron Therapeutics, Inc. · Granted Oct 15, 2024 · Expires Oct 10, 2044

    granted

  4. US 12115255

    Methods of use of emulsion formulations of an NK-1 receptor antagonist

    Heron Therapeutics, Inc. · Granted Oct 15, 2024 · Expires Oct 10, 2044

    granted

  5. US 11878074

    Methods of use of emulsion formulations of an NK-1 receptor antagonist

    Heron Therapeutics, Inc. · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted

  6. US 11844837

    Compositions of a polyorthoester and an organic acid excipient

    Heron Therapeutics, Inc. · Granted Dec 19, 2023 · Expires Dec 14, 2043

    granted

  7. US 11744800

    Methods of use of emulsion formulations of an NK-1 receptor antagonist

    Heron Therapeutics, Inc. · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

  8. US 11413350

    Long-acting polymeric delivery systems

    Heron Therapeutics, Inc. · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted

  9. US 11253504

    Compositions of a polyorthoester and an aprotic solvent

    Heron Therapeutics, Inc. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  10. US 11173118

    Emulsion formulations of an NK-1 receptor antagonist and uses thereof

    Heron Therapeutics, Inc. · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted

  11. US 11083730

    Long-acting polymeric delivery systems

    Heron Therapeutics, Inc. · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted

  12. US 11083797

    Long-acting polymeric delivery systems

    Heron Therapeutics, Inc. · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted

  13. US 10980886

    Compositions of a polyorthoester and an organic acid excipient

    Heron Therapeutics, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  14. US 10953018

    Emulsion formulations of aprepitant

    Heron Therapeutics, Inc. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  15. US 10898575

    Long-acting polymeric delivery systems

    Heron Therapeutics, Inc. · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted

  16. US 10632199

    Long-acting polymeric delivery systems

    Heron Therapeutics, Inc. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  17. US 10624850

    Emulsion formulations of an NK-1 receptor antagonist and uses thereof

    Heron Therapeutics, Inc. · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  18. US 10500208

    Emulsion formulations of aprepitant

    Heron Therapeutics, Inc. · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  19. US 10398686

    Compositions of a polyorthoester and an aprotic solvent

    Heron Therapeutics, Inc. · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted

  20. US 10357570

    Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron

    Heron Therapeutics, Inc. · Granted Jul 23, 2019 · Expires Jul 18, 2039

    granted

  21. US 10213510

    Long-acting polymeric delivery systems

    Heron Therapeutics, Inc. · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  22. US 10098957

    Long-acting polymeric delivery systems

    Heron Therapeutics, Inc. · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  23. US 9974794

    Emulsion formulations of aprepitant

    Heron Therapeutics, Inc. · Granted May 22, 2018 · Expires May 17, 2038

    granted

  24. US 9974742

    Emulsion formulations of an NK-1 receptor antagonist and uses thereof

    Heron Therapeutics, Inc. · Granted May 22, 2018 · Expires May 17, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.